First, antigen‐specific CD8+ T‐cell responses directed against all four TAA analyzed were readily observed in more than 50% of HCC patients, significantly greater than the corresponding frequency of detection in healthy donors or patients with viral hepatitis. The gene discussed is CD8A; the disease is hepatocellular carcinoma.